The effect of B-cell depletion with an anti-CD20 antibody on the immunoglobulin heavy-chain repertoire in a patient with rheumatoid arthritis

被引：0
|
作者：
Rouziere, A-S
Kneitz, C.
Doerner, T.
Tony, H-P
机构：
[1] Charite Univ Hosp, Berlin, Germany
[2] Univ Wurzburg, Dept Med 2, D-97070 Wurzburg, Germany
来源：
ARTHRITIS RESEARCH & THERAPY | 2005年 / 7卷
关键词：
Rheumatoid Arthritis Patient; Related Sequence; Gene Usage; Somatic Hypermutation; Good Clinical Response;
D O I：
10.1186/ar1647
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S46 / S46
页数：1
相关论文
共 50 条
  • [21] Ofatumumab, a Novel Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell Malignancies
    Cheson, Bruce D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (21) : 3525 - 3530
  • [22] Anti-CD20 monoclonal antibody as a new treatment modality for B-cell lymphoma
    Hotta, T
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 2002, 35 (04) : 275 - 279
  • [23] Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody
    Abou Mourad, Y
    Taber, A
    Chehal, A
    Shamseddine, A
    ANNALS OF HEMATOLOGY, 2004, 83 (05) : 319 - 321
  • [24] Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies
    Fagnano, Ester
    Pendharkar, Swati
    Colton, Madyson
    Jones, Philip N.
    Sallan, Marta Crespi
    Klymenko, Tetyana
    Braun, Andrejs
    Klein, Christian
    Honeychurch, Jamie
    Cheadle, Eleanor J.
    Illidge, Timothy M.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [25] Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody
    Yasser Abou Mourad
    Ali Taher
    Aref Chehal
    Ali Shamseddine
    Annals of Hematology, 2004, 83 : 319 - 321
  • [26] Understanding the mechanistic basis in rheumatoid arthritis for clinical response to anti-CD20 therapy: the B-cell roadblock hypothesis
    Silverman, Gregg J.
    Boyle, David L.
    IMMUNOLOGICAL REVIEWS, 2008, 223 : 175 - 185
  • [27] B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies
    Leandro, Maria J.
    ARTHRITIS RESEARCH & THERAPY, 2013, 15
  • [28] Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series
    Øystein Fluge
    Olav Mella
    BMC Neurology, 9
  • [29] Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series
    Fluge, Oystein
    Mella, Olav
    BMC NEUROLOGY, 2009, 9
  • [30] B-cell depletion in patients with multiple myeloma with the anti-CD20 monoclonal antibody rituximab after high dose therapy
    Witzens, M
    Gemmel, C
    Moos, M
    Goldschmidt, H
    Ho, AD
    BONE MARROW TRANSPLANTATION, 1999, 23 : S141 - S141
12345